CausalSentinel

Protein Dossier — CPB1 (Carboxypeptidase B)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Ulcerative colitis -0.213 0.0585 2.66e-04 Wald ratio 1 trans NA
Diagnoses - main ICD10: K43 Ventral hernia 0.279 0.0894 0.00183 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: K43 Ventral hernia 0.279 0.0894 0.00183 Inverse variance weighted 2 trans NA
Multiple sclerosis -0.228 0.0739 0.00205 Wald ratio 1 trans NA
Cigarettes smoked per day -1.18 0.387 0.00232 Wald ratio 1 cis NA
Inflammatory bowel disease -0.143 0.0473 0.00248 Wald ratio 1 trans NA
Diagnoses - main ICD10: G47 Sleep disorders 0.224 0.0819 0.00616 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: G47 Sleep disorders 0.224 0.0819 0.00616 Inverse variance weighted 2 trans NA
Birth length 0.119 0.0449 0.008 Wald ratio 1 cis NA
Systemic lupus erythematosus 0.555 0.218 0.0108 Wald ratio 1 cis NA
Diagnoses - main ICD10: S76 Injury of muscle and tendon at hip and thigh level 0.553 0.227 0.0148 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: S76 Injury of muscle and tendon at hip and thigh level 0.553 0.227 0.0148 Inverse variance weighted 2 trans NA
…and 153 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

20 association rows across 18 traits (16 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
CPA1/CPB1 protein level ratio 2e-268 rs1059502 1 GCST90314202 no MR -> candidate analysis
CPB1/PRSS2 protein level ratio 6e-138 rs1059502 1 GCST90314211 no MR -> candidate analysis
Circulating CPB1 levels 2e-104 rs2331406 2 GCST90859977 no MR -> candidate analysis
CELA3A/CPB1 protein level ratio 3e-99 rs1059502 1 GCST90314010 no MR -> candidate analysis
CPB1/CTRB1 protein level ratio 9e-95 rs1059502 1 GCST90314208 no MR -> candidate analysis
CPB1 protein levels 8e-76 rs2331406 1 GCST90468839 no MR -> candidate analysis
Carboxypeptidase B levels 5e-71 rs2291671 1 GCST90246875 no MR -> candidate analysis
Carboxypeptidase B (analyte X6356.3) levels 4e-64 rs6803439 1 GCST90426645 no MR -> candidate analysis
Cerebrospinal fluid protein CPB1 levels 2e-63 rs6803439 1 GCST90944727 no MR -> candidate analysis
Carboxypeptidase B (analyte X15375.49) levels 2e-54 rs6803439 1 GCST90422627 no MR -> candidate analysis
Serum levels of protein CPB1 3e-35 rs13318851 1 GCST90089361 no MR -> candidate analysis
Blood protein levels 1e-19 rs13318853 1 GCST006585 no MR -> candidate analysis
…and 6 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 290 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Abnormality of the integument 0.46 common-variant locus no MR -> candidate analysis
kidney transplant 0.388 common-variant locus no MR -> candidate analysis
smoking initiation 0.092 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.091 common-variant locus no MR -> candidate analysis
ovarian dysfunction 0.076 common-variant locus no MR -> candidate analysis

Of the 5 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Carboxypeptidase B)
gnomAD constraint pLI=4.6e-19, LOEUF=1.3 — LoF-tolerant
GWAS Catalog 29 unique SNPs / 55 rows
ClinVar 97 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance